MacroGenics Inc (NASDAQ:MGNX)
| 17.93 Delayed Data As of 3:59pm ET |  -0.84 / -4.48%Today’s Change | 17.29 Today|||52-Week Range 36.48 | -21.57% Year-to-Date |
Latest MGNX News | Press Releases
No recent news for MacroGenics Inc.
Today’s Trading
| Previous close | 18.77 |
| Today’s open | 18.77 |
| Day’s range | 17.83 - 19.08 |
| Volume | 13,264 |
| Average volume (3 months) | 597,325 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 11/29/2021
Growth & Valuation
| Earnings growth (last year) | +21.65% |
| Earnings growth (this year) | -31.52% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +63.40% |
| P/E ratio | NM |
| Price/Sales | 11.43 |
| Price/Book | 3.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRNXCrinetics Pharmaceut... | -0.56 | -2.30% |
| MNKDMannKind Corp | +0.01 | +0.32% |
| INVAInnoviva Inc | -0.21 | -1.24% |
| ---- |
Data as of 3:59pm ET, 11/29/2021
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $104.9M |
| Annual profit (last year) | -$129.7M |
| Net profit margin | -123.70% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
